The U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA-NIFA) awarded a $9.5M project grant under the Extension Collaborative on Immunization Teaching & Engagement (EXCITE) program to the Extension Foundation. This grant, spanning from Sep 2024 to May 2027, aims to stabilize and increase routine immunization rates in rural and underserved communities. The key objectives are to: 1) increase public confidence in adult vaccinations through collaboration with...
This federal Cooperative Agreement award, with a total funding amount of $3,047,740.00, was provided by the National Center for Immunization and Respiratory Diseases, a division of the Centers for Disease Control and Prevention (CDC). The award supports the "Partnerships to Enhance Immunization Information Systems" project under the CDC's Federal Grant Program CFDA 93.185 "Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills...
The Department of Agriculture's National Institute of Food and Agriculture (NIFA) awarded a 5-year, $10,000,000 Project Grant under the Agriculture and Food Research Initiative (AFRI) program to the Extension Foundation. The grant will support the ECOP Workforce Develop Program Action Team, the NECIW National Working Group (NWG), and EXF in forming a robust network of public and private entities across the U.S. to build the nation's capacity to respond to changing needs in the food and...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) will provide $1,050,000.00 over a five-year period starting September 30, 2024 to the University of Arizona to enhance vaccine uptake in border and rural regions. The project aims to use community-based participatory research to develop innovative approaches to increase vaccination rates across the...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) provides $5,600,000.00 to Interchurch Medical Assistance, Inc. over the period of Sep 30, 2024 to Sep 29, 2029. The award is intended to strengthen immunization program implementation in sub-national consequential geographies. As the prime grantee, Interchurch Medical Assistance will leverage its expertise in global health, health systems...
The Department of Agriculture National Institute of Food and Agriculture awarded a $300,000 cooperative agreement to the Extension Foundation from October 2021 through September 2023 under the Grants for Agricultural Research, Special Research Grants program (CFDA 10.200). The award will support the Extension Foundation in developing a roadmap for implementing the five recommendations recently outlined in Cooperative Extension's National Framework for Health Equity and Well-Being. As the Special...
This federal Cooperative Agreement award in the amount of $1,050,000.00 was issued on September 30, 2024 by the National Center for Immunization and Respiratory Diseases, part of the Centers for Disease Control and Prevention (CDC). The award is funded under the CDC's Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program, which aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. The award will...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Program (CFDA 93.323) provides $799,904.00 in funding to New York University School of Medicine. The award, with a project period from September 30, 2024 to September 29, 2029, supports the ARISE Coordinating and Collaborating Centers for the Study of Vaccine Hesitancy and Uptake. The project aims to enhance public health...
The University of California, Irvine received a $33,116,067 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct basic and translational research for developing prototype vaccines against emerging viruses. The key products and services to be delivered include: Characterization and comparison of two universal, programmable, rapid response vaccine platforms: an...
The University of Massachusetts Medical School was awarded a $1,049,646 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. The award, which runs from September 30, 2024 to September 29, 2029, is for the ARISE Center for Rural Vaccination project. The project aims to enhance public health infrastructure and capacity for detecting, responding to, preventing, and controlling...